CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation
NCT02910752
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
SUSPENDED
Status
20
Enrollment
OTHER
Sponsor class
Stopped
Low enrollment
Conditions
Leukemia
Interventions
DRUG:
CLAM+PBSC
Sponsor
Shanghai Jiao Tong University School of Medicine